HKUMed Pioneers Global Liver Cancer Treatment with Innovative Dual Immunotherapy, Enhancing Patient Survival and Securing International Approvals
A groundbreaking advancement in the treatment of advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, has emerged from the collaborative efforts of...